Tudor Investment Corporation »

Xeris Pharmaceuticals shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 553k 2.35
2023-09-30 $1.2M 642k 1.86
2023-06-30 $2.2M 858k 2.62
2023-03-31 $1.6M 960k 1.63
2022-12-31 $1.3M 960k 1.33
2022-09-30 $1.5M 960k 1.56
2022-06-30 $1.5M 960k 1.54
2022-03-31 $2.5M 961k 2.56
2021-12-31 $2.8M 960k 2.93

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Splunk Inc - US Equity
Pioneer Natural Resources Co - US Equity (PXD)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Spdr Dow Jones Industrial Average Etf Trust - US E ETF Option Call Option (DIA)
Exxon Mobil Corp - US Equity (XOM)
Meta Platforms Inc - US Equity (META)
Bristol-Myers Squibb Co - US Equity (BMY)
Texas Instruments Inc - US Equity Option Call Option (TXN)
Enphase Energy Inc - US Equity Option Call Option (ENPH)
United Parcel Service Inc - US Class B Equity Option Call Option (UPS)
Nvidia Corp - US Equity (NVDA)
Bank Of America Corp - US Equity (BAC)
Estee Lauder Cos Inc/The - US Equity (EL)

View all positions for Tudor Investment Corporation

Top funds holding Xeris Pharmaceuticals

Vanguard Group
Rosalind Advisors
Millennium Management
D. E. Shaw & Co
Redmile Group
Citadel Advisors
Invenomic Capital Management
Tudor Investment Corporation
Lazard Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Jpmorgan Chase & Co
Barclays
AQR Capital Management
Alpine Partners VI

View all funds holding Xeris Pharmaceuticals